| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4f57c7d8b0000a1da436609b4fa6b93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d633d39fc95fc2aae960fa2892fc6b5a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate |
2006-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b0bdbd7efd1d6e32602015809b4516e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dfdd268c70f96d459c5b732610f19d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a519059dddd27d1460daeaa36b3d27f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56dcd276811a81c5466a78c8fac5f010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a95bc192dcd3e5d6b3fac2fe44d1432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91f0cce08109e0c64b24a1c0bc06fa0 |
| publicationDate |
2008-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1931330-A1 |
| titleOfInvention |
Composition comprising tanshinone compounds isolated from the extract of salviae miltiorrhizae radix for treating or preventing cognitive dysfunction and the use thereof |
| abstract |
The present invention relates to a composition comprising tanshinone compounds selected from the group consisting of miltirone, 1,2-didehydromiltirone, tanshinone I IA, tanshinone I and di hydro tanshinone I isolated from Salviae Miltiorrhizae Bunge showing potent inhibiting effect on the aggregation and toxicity of beta-amyloid and recovering activity of memory learning disorder confirmed by Y maze study and Passive Avoidance study. Therefore it can be used as the therapeutics or health food for treating and preventing cognitive function disorder with safe. |
| priorityDate |
2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |